Search clinical trials for: AZD8154 nebuliser

Total 309 results

AstraZeneca
Parexel

Terminated

Evaluation of AZD8154 Concentrations in Blood

Asthma

Germany
AstraZeneca
Parexel

Withdrawn

A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen

Asthma

Canada
Sultan Abdulhamid Han Training and Research Hospital...

Recruiting

Evaluation of the Efficacy of Different Nebulization Techniques

COPD Exacerbation

Turkey
AstraZeneca
Parexel

Completed

A Study to Evaluate the Safety, Tolerability and Absorption to the Blood After Administration of Single and Multiple Doses of AZD8154 in Healthy Participants.

Asthma

Germany
Cliniques universitaires Saint-Luc- Université...

Unknown

Comparison of Lung Administration With Three Different Nebulizer

Healthy Subjects

Belgium
Centre Hospitalier Universitaire de Nīmes

Completed

Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age (LC SPRINT Sp)

Asthma

France
Christiana Care Health Services

Withdrawn

Breath Actuated Nebulizer Study Protocol

Chronic Obstructive Pulmonary Disease | Asthma

United States
Medstar Health Research Institute

Withdrawn

Medicated Aerosol Delivery Using A Jet Nebulizer Versus A Vibrating Mesh Nebulizer in COPD Exacerbation

Chronic Obstructive Pulmonary Disease

United States
NHS Greater Clyde and Glasgow
Aerogen

Unknown

Borg Score Outcomes in Respiratory Compromised Acute Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Treatment Via Vibrating Mesh Nebuliser Versus Jet Nebuliser in the Emergency Department (BRAVE)

COPD | COPD Exacerbation

United Kingdom
Fondazione Policlinico Universitario Agostino Gemelli...
University of Florence, UNIFI University of Florence, Florence, Italy Florence

Not yet recruiting

Impact of Switching COPD Patients From Inhaler Devices to the Omron C28P Nebuliser. (OMRON)

COPD (Chronic Obstructive Pulmonary Disease) With Acute Lower Respiratory Infection
Oxford University Hospitals NHS Trust
University of Manchester; The Christie NHS Foundation Trust; Early Phase Cancer...

Completed

AZD1152 in Diffuse Large B-cell Lymphoma

Lymphoma

United Kingdom
AstraZeneca

Completed

Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia

Myeloid Leukemia

United States, Italy, Netherlands, France
AstraZeneca

Completed

Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)

Acute Myeloid Leukaemia

Japan
AstraZeneca

Active, not recruiting

Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

COVID-19, SARS-CoV-2

Japan
AstraZeneca

Recruiting

Study of AZD0754 in Participants With Metastatic Prostate Cancer (APOLLO)

Metastatic Prostate Cancer

United States, Australia
AstraZeneca

Terminated

AZD1152 in Patients With Advanced Solid Malignancies-Study 1

Solid Tumors

Netherlands
AstraZeneca

Terminated

AZD1152 in Patients With Advanced Solid Malignancies-Study 3

Solid Tumours

United Kingdom
University Hospital St Luc, Brussels
Université Catholique de Louvain; Haute Ecole de Santé Vaud; Ligue Pulmonaire...

Completed

Pharmacokinetics of Nebulized Amikacin in Non Invasive Ventilated Healthy Volunteers. (NIV-NEBU)

Chronic Respiratory Insufficiency | Acute Respiratory Insufficiency | Bronchospasm and Obstruction

Belgium
Chang Gung University

Completed

Aerosol Delivery in Different Types of Nebulizers

Asthma
Milton S. Hershey Medical Center

Terminated

Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound

Pneumonia | Mediastinal Lymphadenopathy | Bronchiectasis Adult | Chest--Diseases | Cancer, Lung | Bronchopulmonary Disease | Infiltrates

United States
AstraZeneca

Not yet recruiting

LTFU for All Cell and Gene Therapy Studies (LOCUS)

Hepatocellular Carcinoma | Prostate Cancer

United States
Cliniques universitaires Saint-Luc- Université...
Fonds National de la Recherche Scientifique

Unknown

Study of the Aerosol Deposition With Vented and Unvented Jet Nebulizer in Healthy Subjets

Aerosol Drug Therapy

Belgium
AstraZeneca

Terminated

A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects (JSMAD)

Healthy

United Kingdom
AstraZeneca
Parexel

Recruiting

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 Following Single and Multiple Ascending Doses Via Oral Administration to Healthy Participants

Healthy Participants

United States
AstraZeneca

Completed

AZD1152 in Patients With Advanced Solid Malignancies

Tumors

United States
Hamilton Health Sciences Corporation

Completed

The Effects Of Methacholine Challenge Administered Using Three Different Nebulizers On Small Airways Function

Asthma

Canada
Tufts Medical Center

Completed

Effectiveness of the Aeroneb in Acute Severe Asthma

Asthma Exacerbation

United States
AstraZeneca

Active, not recruiting

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study (SUPERNOVA)

COVID-19, SARS-CoV-2

United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

Using Remote Telemonitoring to Detect Early Decline in Lung Function & Streamline Clinics in Adults With Cystic Fibrosis (RIGHT-CF)

Cystic Fibrosis

United Kingdom
National Cancer Institute (NCI)

Terminated

AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites

Gastrointestinal Neoplasms | Ovarian Neoplasms | Ovarian Cancer | Ascites | Gastrointestinal Cancer

United States
AstraZeneca

Completed

An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)

Acute Myeloid Leukaemia

United Kingdom
Eda SORKUN

Completed

The Effect of Sound-Insulated Music Playing and Fıgured Mask Nebulızer Application on the Processing Anxiety of Children

Anxiety | Child, Only

Turkey
Riphah International University

Completed

Effects of Pranayama Breathing Technique in Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Pakistan
Cliniques universitaires Saint-Luc- Université...

Unknown

Comparison of Amikacin Lung Delivery With Two Nebulizers

Healthy | Cystic Fibrosis

Belgium
Sunovion Respiratory Development Inc.

Completed

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4) (GOLDEN-4)

Chronic Obstructive Pulmonary Disease | COPD

United States
AstraZeneca

Completed

An Open Label Prostate Cancer Study in Japanese Patients

Prostate Cancer

Japan
University of Giessen

Completed

GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia (GI-COVID)

COVID-19 Pneumonia | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Germany
AstraZeneca

Active, not recruiting

Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

COVID-19

United States
GlaxoSmithKline

Completed

First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients

Idiopathic Pulmonary Fibrosis

United Kingdom
Chang Gung University
Chang Gung Memorial Hospital

Completed

Aerosolized Colistin to Mechanical Ventilated Patients With Pneumonia (CRGNB)

Pneumonia, Bacterial

Taiwan
University of Leipzig

Completed

Combination of NHF and Nebulizer on Lung Function in COPD (AEROFLOW)

Chronic Obstructive Pulmonary Disease

Germany
Sunovion Respiratory Development Inc.

Completed

Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-3)

COPD

United States
The Hospital for Sick Children

Completed

AeroEclipse II Agreement

Asthma

Canada
AstraZeneca

Terminated

A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease

Healthy | COPD

Sweden
AstraZeneca

Completed

Positron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ Amyloid (PET)

Alzheimer's Disease

Sweden
AstraZeneca
Ionis Pharmaceuticals, Inc.

Completed

A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Advanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma Metastatic

Korea, Republic of, Taiwan, Hong Kong, Japan
Centre d'Investigation Clinique et Technologique...

Unknown

Salbutamol in the Pediatric Emergencies: Nebulization Estimated Via AerogeN or Jet (SIBILANT)

Asthma
University of Nottingham

Unknown

A Comparison of Two Nebulisers for Sputum Induction (FLAME)

Asthma | COPD

United Kingdom
AstraZeneca

Terminated

Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects

Thrombin Inhibition

United States
Regenexx, LLC

Terminated

Nebulized PL for Post-COVID-19 Syndrome

Covid19

United States

Search clinical trials for: AZD8154 nebuliser

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations